Upcoming Event - Clinical Trials in Asia
6/13/2008
Event: Clinical Trials in Asia
Date(s): September 8-9, 2008
Venue: Hilton Short Hills - Short Hills, New Jersey, USA
Organizer: ExL Pharma
Contact: ExL Events, Inc.
Tel: +1 866-207-6528
Fax: +1 888-221-6750
Email: register@exlpharma.com
Weblink: www.exlpharma.com/eventDetail.php?id=129
Interest and integration of running clinical trials in Asia has grown extensively in the past few years. This immense growth, while beneficial for organizations looking to expedite trials through shorter timelines and lower costs, seems to have come faster than many of the countries can accommodate- while they accept more and more trials, their regulatory authorities are slow to create regulations to accommodate the trials and its participants. In addition to a host of other obstacles, ultimately each country's regulations are different, resulting in US companies expending additional time and resources to plan and conduct clinical trials abroad. With so much variation and growth in this arena, what solutions are available to pharmaceutical organizations to ensure that their outsourced clinical trials will be run within regulatory guidelines in an efficient, cost-effective manner?
Organized by ExL Pharma, Clinical Trials in Asia is a two-day conference dedicated to providing solutions for overcoming obstacles associated with outsourcing clinical trials to Asia. Strategic presentations focused on trials in China and India allow attendees to hear the latest updates on regulations, growth and tactics for working effectively through language and cultural barriers to guarantee effective completion of trials abroad.
This conference features a speaking faculty composed of experts with extensive experience in conducting clinical trials in China, India, and other up and coming research centers throughout Asia. Gergana Zlateva, PhD of Pfizer will present a case study on adapting Quality of Life questionnaires and Patient Reported Outcomes to local customs and dialects to ensure quality results. Helen Niu, MD, PhD of Amgen will also present a case study, focused on the regulatory and operational challenges of conducting clinical trials in emerging regions on the continent. In addition, James Cai, MD, Vice President of Research & Development for AstraZeneca China, will share his expertise on overcoming regulatory hurdles in China and Mohanish Anand, PhD, Head, Clinical Research for Pfizer Limited in India will speak on effective methods of establishing relationships with local CROs. Additional sessions will feature presentations on protecting intellectual property abroad, challenges of working in an immature labor market, and expediting timelines. Attendees will have ample opportunities for interaction with our panel of experts to glean personalized information on the launch of Asian clinical trials in their own companies.
Gain Valuable Insight and Hear Solutions from Peers in the Interactive Roundtables, Discussing:
- What ethical concerns are associated with conducting trials in Asia?
- What are the most effective ways to import clinical materials and distribute them when preparing to run a drug trial abroad?
- What are strategies for overcoming the language barrier to gain informed consent for compliant patient recruitment?
- What are the potential effects of alternative medicine on protocol compliance?
- What approaches work best for training and creating autonomy with your staff abroad?